Research Associate Professor
Laboratory: Lab of Phenotypic Screening
Research interested:
1)Antibody induced cell fate conversion
2)The role of Chemokine receptor in cancer immunology
Email: wangju@@shanghaitech.edu.cn
Biography:
B.S, Clinical medicine, Fudan University, 2004
M.S, Genetics, Peking Union Medical College, 2007
Ph.D, Pharmacognosy, China Pharmaceutical University, 2012
2007-2008, Assistant Scientist, National Drug Screening Center, Shanghai, China
2008-2010, Associate Scientist, GlaxoSmithKline R&D China, Shanghai,China
2010-2013, Velox Pharmaceutical, Inc. Director of Translational Medicine, Changhzou, China
2014-present, Research associate professor, Shanghai institute for advanced immunochemical studies
Representative Publications:
Ju Wang, Zi-Qi Shi, Gui-Zhong Xin, Xiao-Jun Xu, Ping Li*,Camptothecin and its analogs reduce amyloid-β production and amyloid-β42-induced IL-1β production, J Alzheimers Dis. 2015 Jan 1.43(2):465-77.
Ju Wang, Zi-Qi Shi, Gui-Zhong Xin, Li Duan, Ping Li*, Triptolide inhibits amyloid-β production and protects neural cells by inhibiting CXCR2 activity, JAD, 2013;33(1):217-29
